Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

56.82 -0.01 (-0.02%)
Streaming Delayed Price Updated: 1:57 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
CVS Health Q3 Earnings Preview: Can The Company Overcome Recent Challenges?
CVS Health is preparing to report Q3 earnings after cutting its annual profit guidance and implementing leadership changes. 
Via Benzinga
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Cigna Considers Humana Acquisition – What It Means for the Stocks
Rumors swirl around a potential Cigna (CI) and Humana (HUM) merger, but Medicare Advantage costs pose a significant challenge, making the merger risky. 
Via MarketBeat
Looking Into CVS Health's Recent Short Interest
Via Benzinga
What the Options Market Tells Us About CVS Health
Via Benzinga
Where CVS Health Stands With Analysts
Via Benzinga
CVS Health Unusual Options Activity For October 17
Via Benzinga
Hims & Hers Stock Dropped: Here's What You Need to Know
The GLP-1 drama continues at Hims & Hers. 
Via The Motley Fool
Walmart Launches Same-Day Pharmacy Delivery, Upping Competition For CVS, Walgreens
Walmart announced on Tuesday that it will begin offering Pharmacy Delivery services both new prescriptions and medication refills, intensifying competition in the pharmacy retail space. 
Via Benzinga
ASML's Latest Chapter in the Semiconductor Story
We've also got a look at genetic testing company 23andMe . 
Via The Motley Fool
Walgreens Stock Rally: 4 Reasons WBA Could Be a Strong Buy
Walgreens Boots Alliance (WBA) is down 60% from its 52-week high, but improving earnings, cost cuts, and a 9.27% dividend yield signal potential recovery. 
Via MarketBeat
CVS Health Preannounces Large Earnings Miss, But Analysts Stay Bullish On Long-Term Recovery
CVS Health Corp (NYSE: CVS) preannounces earnings miss for Q3. Analysts maintain ratings after CEO change. 
Via Benzinga
Topics Earnings
Exposures Financial
Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms
Cigna and Humana are in early-stage merger discussions after a year-long pause. Amid financial pressure, Humana's Medicare Advantage star ratings have plummeted, impacting future revenue. 
Via Benzinga
NIO, ASML, And CVS Health Are Among Top 10 Large Cap Losers Last Week (Oct 14-18): Are The Others In Your Portfolio?
10 worst performing stocks last week: NIO -16.35%, KLAC -15.58%, CNC -14.38%, Elevance -14.17%, ASML -13.97%, PDD -13.91%, MOH -12.24%, LRCX -12.12%, ERIE -9.92%, CVS -9.44% 
Via Benzinga
2 "Safe" Healthcare Stocks That Are Anything But
If you buy these stocks, you might be in for serious disappointment when they underperform. 
Via The Motley Fool
Stocks Rise, Netflix Soars To Record Highs, Oil Falls Below $70, Gold Miners Rally: What's Driving Markets Friday?
Wall Street was in positive territory in Friday midday trading, buoyed by upbeat quarterly earnings reports that kept investor sentiment bullish. 
Via Benzinga
Crude Oil Down Over 1%; American Express Shares Fall After Q3 Results
Via Benzinga
Exposures Fossil Fuels
Elevance, CVS, UnitedHealth Struggle With Rising Medical Costs After COVID-19 Medicaid Policy Ends
Insurers have reported higher medical costs due to the end of pandemic-era policies. States redetermining Medicaid eligibility created a disparity for insurers. 
Via Benzinga
Exposures COVID-19
CVS Health Cuts Outlook, Joins American Express And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
US Stocks Set To End Week Strong As Netflix Q3 Earnings Boost Optimism, Gold Hits New Highs: What's Driving Sentiment Friday?
Wall Street is priming for a positive start on Friday after the major averages ended narrowly mixed in the previous session. 
Via Benzinga
Pharmacy Retailer CVS Health Backs Away From Annual Forecast, Names New CEO
CVS Health replaces CEO Karen Lynch with David Joyner as the company struggles with lower earnings projections and rising medical costs. Q3 2024 results, including a $1.1 billion charge, are expected... 
Via Benzinga
Amazon's Latest Healthcare Move Could Be a Big Problem for Walgreens and CVS
Amazon looks to significantly ramp up its online pharmacy business. 
Via The Motley Fool
Why CVS Health Stock Is Trading Lower
CVS Health shares are trading lower by 3.8% during Tuesday's session. Health insurer stocks are down after UnitedHealth reported Q3 results and cut its annual EPS outlook. 
Via Benzinga
CVS Health: Are Its Parts Worth More Than the Whole?
CVS Health Co. (NYSE: CVS) transformed from one of the largest drug store pharmacy chains in the country to an integrated healthcare company 
Via MarketBeat
Welcome To The “Pain Trade” - Here’s What To Do About It
The market is grinding higher, satisfying pretty much nobody. The bulls are left wanting more, whereas the bears who were short the market are forced to cover. 
Via Talk Markets
Troubled Victoria’s Secret stock could surge by 72%
Victoria’s Secret (VSCO) stock has stabilized in the past few weeks as investors focus on the recent leadership transition and the ongoing turnaround. 
Via Talk Markets
Wall Street's Top 10 Stock Calls This Week - Saturday, Oct. 12
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Oct. 7-11, 2024. 
Via Talk Markets
Where Does Hims & Hers Stock Go From Here?
Is Hims & Hers in trouble since the FDA put a time clock on some GLP-1s, or is the future still bright? 
Via The Motley Fool
Exposures Product Safety
CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter
Via Benzinga
CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst
Barclays upgrades CVS Health to Overweight, citing gains in pharmacy market share and potential upside from CostVantage. CVS is expected to recover 200 basis points in Medicare margins by 2026,... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.